Health Equity Considerations in Cost-Effectiveness Analysis: Insights from an Umbrella Review

Jeffrey M Muir,1 Amruta Radhakrishnan,1 Ipek Ozer Stillman,2 Grammati Sarri3 1RWA Health Economics, Cytel Inc., Toronto, ON, Canada; 2Value, Evidence & Health Economics, Takeda Pharmaceuticals, Lexington, MA, USA; 3RWA Health Economics, Cytel Inc., London, UKCorrespondence: Grammati Sarri, Evidence,...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Muir JM, Radhakrishnan A, Ozer Stillman I, Sarri G
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Dove Medical Press 2024-08-01
Edice:	ClinicoEconomics and Outcomes Research
Témata:	health technology assessment health equity cost-effectiveness analysis value elements umbrella review
On-line přístup:	https://www.dovepress.com/health-equity-considerations-in-cost-effectiveness-analysis-insights-f-peer-reviewed-fulltext-article-CEOR
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!